ConductScience.org, home

Paper533255

Rifampin plus trimethoprim: bactericidal activity and suppression of resistance in human urine in vitro.

Goldstein BP and 4 others. Antimicrob Agents Chemother, 1979. Cited by 12 papers, by iCite.

Cite this record

ConductScience Library. Rifampin plus trimethoprim: bactericidal activity and suppression of resistance in human urine in vitro. Papers, record 533255. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/533255

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Rifampin plus trimethoprim: bactericidal activity and suppression of resistance in human urine in vitro.
PubMed
Journal
Antimicrob Agents Chemother
PubMed
Year
1979
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
12
iCite
Relative citation ratio, by iCite
0.74
iCite
Revised in PubMed
2021-05-26
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Goldstein BPB P
2Ripamonti IFI F
3Bolzoni GG
4Carniti GG
5Arioli VV

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
BacteriaMajor topic
RifampinMajor topic
TrimethoprimMajor topic
UrineMajor topic
Drug Interactions
Drug Resistance, Microbial
Humans
Microbial Sensitivity Tests
Sulfamethoxazole
Thymine
Time Factors

Source PubMed

Download CSV of topics

References20

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
114329476IMPROVED METHOD FOR THE ISOLATION OF THYMINE-REQUIRING MUTANTS OF ESCHERICHIA COLI.J Bacteriol1965https://conductscience.org/library/papers/14329476PubMed
3412502Thymidine concentrations in serum and urine of different animal species and man.Biochem Pharmacol1977https://conductscience.org/library/papers/412502PubMed
4409709The interactions between rifampicin and trimethoprim: an in vitro study.J Antimicrob Chemother1977https://conductscience.org/library/papers/409709PubMed
5383553Controlled clinical trial of a rifampicin- trimethoprim combination (Rifaprim) and cotrimoxazole in patients with chronic urinary tract infections.J Int Med Res1979https://conductscience.org/library/papers/383553PubMed
6344347Effect of thymidine on activity of trimethoprim and sulphamethoxazole.J Clin Pathol1978https://conductscience.org/library/papers/344347PubMed
7324966The use of antibiotic combinations in the treatment of Serratia marcescens infections.J Antimicrob Chemother1977https://conductscience.org/library/papers/324966PubMed
8321415Interaction between rifampicin and trimethoprim in vitro and in experimental infections.J Antimicrob Chemother1977https://conductscience.org/library/papers/321415PubMed
9621731Human infections with thymine-requiring bacteria.J Med Microbiol1978https://conductscience.org/library/papers/621731PubMed
10903326The action of trimethoprim and rifampicin in combination against Gram-negative rods resistant to gentamicin.J Antimicrob Chemother1977https://conductscience.org/library/papers/903326PubMed
11977527
Kinetic studies on the combination rifampicin-trimethoprim in man. I. Absorption and urinary excretion after administration to healthy volunteers of single doses of the two compounds alone and in combination, and of the combination over a period of 1 week.
J Antimicrob Chemother1976https://conductscience.org/library/papers/977527PubMed
124385644Rifampicin: a new rifamycin. I. Bacteriological studies.Arzneimittelforschung1967https://conductscience.org/library/papers/4385644PubMed
134275615Trimethoprim action and its analogy with thymine starvation.Antimicrob Agents Chemother1974https://conductscience.org/library/papers/4275615PubMed
144209268Trimethoprim-sensitivity testing and thymineless mutants.J Med Microbiol1974https://conductscience.org/library/papers/4209268PubMed
1556651Thymine-requiring bacteria associated with co-trimoxazole therapy.Lancet1976https://conductscience.org/library/papers/56651PubMed
164575177Nature of trimethoprim-induced death in Escherichia coli.Arzneimittelforschung1973https://conductscience.org/library/papers/4575177PubMed
174584067Thymine-requiring mutants of Proteus mirabilis selected by co-trimoxazole in vivo.J Gen Microbiol1973https://conductscience.org/library/papers/4584067PubMed
184945790Rifampicin, a general review.Arzneimittelforschung1971https://conductscience.org/library/papers/4945790PubMed
194957432Thymidylate synthesis and aminopterin resistance in Bacillus subtilis.J Bacteriol1966https://conductscience.org/library/papers/4957432PubMed
204864067Recovery from "thymineless death" in Escherichia coli 15T.Biochem Biophys Res Commun1967https://conductscience.org/library/papers/4864067PubMed
211206027Trimethoprim and rifampicin: in vitro activities separately and in combination.J Antimicrob Chemother1975https://conductscience.org/library/papers/1206027PubMed

Download CSV of references

Cited by4

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 12 citations.

PMIDTitleJournalYearIn PapersSource
28074051Anti-folates potentiate bactericidal effects of other antimicrobial agents.J Antibiot (Tokyo)2017https://conductscience.org/library/papers/28074051PubMed
7247374Trimethoprim-rifampin, a new combination agent: efficacy in localized urinary infection and influence on microflora.Antimicrob Agents Chemother1981https://conductscience.org/library/papers/7247374PubMed
6759092Co-trimoxazole (trimethoprim-sulfamethoxazole): an updated review of its antibacterial activity and clinical efficacy.Drugs1982https://conductscience.org/library/papers/6759092PubMed
3046481Randomized clinical trial of rifampin-trimethoprim and sulfamethoxazole-trimethoprim in the treatment of localized urinary tract infections.Antimicrob Agents Chemother1988https://conductscience.org/library/papers/3046481PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/533255

GET https://conductscience.org/api/papers/v1/533255/authors